| 0 |
Prostaglandin E1 Analog [EPC] |
2 |
0.0001 |
| 1 |
Provitamin D2 Compound [EPC] |
3 |
0.0001 |
| 2 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
1 |
0.0001 |
| 3 |
Thiazide-like Diuretic [EPC] |
4 |
0.0001 |
| 4 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
4 |
0.0001 |
| 5 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
1 |
0.0001 |
| 6 |
Progesterone [EPC] |
1 |
0.0000 |
| 7 |
Aluminum Complex [EPC] |
1 |
0.0000 |
| 8 |
Proton Pump Inhibitor [EPC] |
12 |
0.0000 |
| 9 |
RANK Ligand Inhibitor [EPC] |
4 |
0.0000 |
| 10 |
Thiazide Diuretic [EPC] |
4 |
0.0000 |
| 11 |
Methylxanthine [EPC] |
1 |
0.0000 |
| 12 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 13 |
beta-Adrenergic Blocker [EPC] |
4 |
0.0000 |
| 14 |
Serotonin Reuptake Inhibitor [EPC] |
1 |
0.0000 |
| 15 |
Purine Antimetabolite [EPC] |
1 |
0.0000 |
| 16 |
Acetylcholine Release Inhibitor [EPC] |
1 |
0.0000 |
| 17 |
Antiarrhythmic [EPC] |
1 |
0.0000 |
| 18 |
Angiotensin 2 Receptor Blocker [EPC] |
3 |
0.0000 |
| 19 |
Parathyroid Hormone Analog [EPC] |
1 |
0.0000 |
| 20 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 21 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 22 |
Platinum-based Drug [EPC] |
2 |
0.0000 |
| 23 |
Leukocyte Growth Factor [EPC] |
1 |
0.0000 |
| 24 |
Calcium [EPC] |
1 |
0.0000 |
| 25 |
Vitamin D [EPC] |
2 |
0.0000 |
| 26 |
Aldosterone Antagonist [EPC] |
1 |
0.0000 |
| 27 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 28 |
Endothelin Receptor Antagonist [EPC] |
1 |
0.0000 |
| 29 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 30 |
Alkylating Drug [EPC] |
1 |
0.0000 |
| 31 |
Osmotic Laxative [EPC] |
1 |
0.0000 |
| 32 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 33 |
Corticosteroid [EPC] |
3 |
0.0000 |
| 34 |
Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 35 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |
| 36 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
2 |
0.0000 |
| 37 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |